Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLMESARTAN MEDOXOMIL vs OLOPATADINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLMESARTAN MEDOXOMIL vs OLOPATADINE: Safety Overview

Metric OLMESARTAN MEDOXOMIL OLOPATADINE
Total FAERS Reports 11,972 8,787
Deaths Reported 283 89
Death Rate 2.4% 1.0%
Hospitalizations 6,564 171
Average Patient Age 66.9 yrs 56.7 yrs
% Female Patients 56.6% 73.2%
FDA Approval Date Apr 13, 2020 Apr 15, 2008
Manufacturer direct rx Alcon Laboratories, Inc.
Route ORAL OPHTHALMIC
Marketing Status Prescription OTC